Are you Dr. Walters?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 26 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
5 Research Pkwy
Wallingford, CT 06492Phone+1 203-677-5752Fax+1 203-677-6691
Summary
- Dr. Ian Walters, MD is a hematologist in Wallingford, Connecticut. He is currently licensed to practice medicine in New York.
Education & Training
Icahn School of Medicine at Mount SinaiResidency, Surgery, 1993 - 1994
Albert Einstein College of MedicineClass of 1993
Certifications & Licensure
NY State Medical License 1994 - 2025
Clinical Trials
- A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 Start of enrollment: 2017 Feb 09
Publications & Presentations
PubMed
- 569 citationsBrivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL StudyPhilip J. Johnson, Shukui Qin, Joong-Won Park, Ronnie T.P. Poon, Jean-Luc Raoul
Journal of Clinical Oncology. 2013-10-01 - 105 citationsBrivanib, a Dual FGF/VEGF Inhibitor, Is Active Both First and Second Line against Mouse Pancreatic Neuroendocrine Tumors Developing Adaptive/Evasive Resistance to VEGF...Elizabeth Allen, Ian Walters, Douglas Hanahan
Clinical Cancer Research. 2011-08-15 - 132 citationsMolecular classification of psoriasis disease-associated genes through pharmacogenomic expression profilingJudith L. Oestreicher, Ian B. Walters, Toyoko Kikuchi, Patricia Gilleaudeau, J Surette
The Pharmacogenomics Journal. 2001-01-01
Press Mentions
- Portage Biotech Highlights Initiation of the Invincible Trial, a Phase 2 Early Stage Breast Cancer Study from Intensity TherapeuticsMarch 25th, 2021
- Clinical Trial Tests in-Tumor Breast Cancer TherapyMarch 24th, 2021
- Juvenescence Scoops-up New Longevity IPMarch 9th, 2021
- Join now to see all
